Drawing for EVIDENCE-DRIVEN ADVOCACY

USPTO serial 85809491

EVIDENCE-DRIVEN ADVOCACY

Reviewed by CopyMark Law Group

Reg. 4504035Status 710
Filing date
Status date
Registration date
Apr 1, 2014
Examiner
HELLMAN, ELI J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with EVIDENCE-DRIVEN ADVOCACY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amie Peele Carter

AMIE PEELE CARTER FAEGRE BAKER DANIELS LLP300 N. Meridian StreetSuite 2700INDIANAPOLIS, IN 46204-1750

Goods and services

ClassDescriptionStatusFirst use
035Providing business marketing information on products in the fields of health care and medical technology; preparing promotional materials for others; business consulting services, namely, business and pricing strategy development for others, product positioning and market research in the fields of health care and medical technology; preparing business reports for others in the fields of health care and medical technology for submission to investors and capital venture companies for the purpose of obtaining investments; lobbying, namely, promoting legislative and regulatory interests of businesses in the field of health care and medical technology in the fields of legislation and regulation; grass root advocacy, namely, promoting the interests of businesses in the field of health care and medical technology; developing promotional campaigns for businesses in the field of health care and medical technology; business services, namely, non-legal agency representation of others before the United States Food and Drug Administration and centers for Medicare and Medicaid; business services, namely, agency representation of others in trade associations in the fields of health care and medical technology; business consultation relating to complaint resolution, product failure investigations and crisis management in the fields of health care and medical technology; facilitating technology transfer for others, namely, providing business advice in the field of technology transfer; conducting due diligence and compliance business audits for others, namely, conducting due diligence and compliance audits relating to business oversight and business mergers in the fields of health care and medical technologySECTION 8 - CANCELLEDMar 17, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 6, 2020C8..CANCELLED SEC. 8 (6-YR)—
Apr 1, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 1, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 14, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 14, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 25, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 6, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 6, 2013ALIEASSIGNED TO LIE—
Nov 13, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 12, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 11, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 11, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 11, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 3, 2013DOCKASSIGNED TO EXAMINER—
May 10, 2013GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2013GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2013CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 9, 2013DOCKASSIGNED TO EXAMINER—
Jan 9, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 25, 2012NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance